Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization

Biomolecules(2024)10.3390/biom14030252Source: DataRank Database

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization is a research paper published in Biomolecules (2024). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 13.35)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Zhao Zhang ORCID,Keith A. Webster ORCID,Yannis M. Paulus ORCID,Yingbin Fu ORCID

Live enrichment

PubMed:38540673 PMC:PMC10968528 OpenAlex:https://openalex.org/W4392016343

BrightFocus Foundation

Grant: 1R01EY033805

BrightFocus Foundation

Grant: 1R01EY034325

BrightFocus Foundation

Grant: 1R01EY033000

BrightFocus Foundation

Grant: 2P30EY002520

BrightFocus Foundation

Grant: P30 EY007003

BrightFocus Foundation

Grant: CDMRP HT9425-23-10179

NIH HHS

Grant: 1R01EY033805 1R01EY034325 1R01EY033000 2P30EY002520 P30 EY007003

NEI NIH HHS

Grant: P30 EY002520

NEI NIH HHS

Grant: R01 EY034325

NEI NIH HHS

Grant: R01 EY033805

NEI NIH HHS

Grant: R01 EY033000

FWCI

13.35

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2218-273X/14/3/252/pdf

publisherhttps://www.mdpi.com/2218-273X/14/3/252/pdf

journalhttps://doi.org/10.3390/biom14030252

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38540673

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10968528

Fields of Study

Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal Development and DisordersMedicine

MeSH Terms

AnimalsCholesterolHumansMacular DegenerationChoroidal NeovascularizationAngiogenesis InhibitorsVascular Endothelial Growth FactorsVascular Endothelial Growth Factor A

Keywords

Macular degenerationChoroidal neovascularizationMedicineNeovascularizationVascular endothelial growth factorVEGF receptorsAngiogenesisOphthalmologyCancer researchAMDApoA-INeovascular Age-related Macular DegenerationCnvAibpAnti-vegf TherapiesCapillary CnvAnti-vegf ResistanceArteriolar Cnv

Sustainable Development Goals

SDG 0: Partnerships for the goals